There is abundant evidence supporting the strong association of PDI proteins with a variety of cancers; for example, P4HB is a potential target for ovarian cancer therapy [44], and increased PDI activity has been demonstrated in melanoma [45]. The gene discussed is P4HB; the disease is ovarian cancer.